We are live on
!
Find out more
Kiniksa Pharmaceuticals
KNSA
KNSA
108 hedge funds and large institutions have $526M invested in Kiniksa Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
40% more call options, than puts
Call options by funds: $3.06M | Put options by funds: $2.19M
34% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 29
27% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 15
20% more capital invested
Capital invested by funds: $437M → $526M (+$88.8M)
4% more funds holding
Funds holding: 104 → 108 (+4)
2.68% more ownership
Funds ownership: 91.42% → 94.09% (+2.7%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
108
Holders Change
+4
Holders Change %
+3.85%
% of All Funds
1.91%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
19
Increased
39
Reduced
29
Closed
15
Calls
$3.06M
Puts
$2.19M
Net Calls
+$866K
Net Calls Change
+$652K
Top Buyers
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$36.4M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$17.6M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$7.23M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$4.3M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.25M |
